Population rates of hospitalization for atrial fibrillation/flutter in Canada
Humphries KH, Jackevicius C, Gong Y, Svensen L, Cox J, Tu JV, Laupacis A; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2004; 20(9):869-76.
Publications
Safety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgery
Cheng DK, Jackevicius CA, Seidelin P, Feindel C, Rouleau JL. Can J Cardiol. 2004; 20(2):223-8.
Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000
Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2004; 20(1):61-7.
Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001
Jackevicius CA, Tu K, Filate WA, Brien SE, Tu JV; Canadian Cardiovascular Outcomes Research Team. Can J Cardiol. 2003; 19(12):1359-66.
Association between ACE inhibitors and acute pancreatitis in the elderly
Cheng RM, Mamdani M, Jackevicius CA, Tu K. Ann Pharmacother. 2003; 37(7-8):994-8.
CCORT/CCS quality indicators for acute myocardial infarction care
Tran CT, Lee DS, Flintoft VF, Higginson L, Grant FC, Tu JV, Cox J, Holder D, Jackevicius C, Pilote L, Tanser P, Thompson C, Tsoi E, Warnica W, Wielgosz A; Canadian Cardiovascular Outcomes Research Team/Canadian Cardiovascular Society; Acute Myocardial Infarction Quality Indicator Panel. Can J Cardiol. 2003; 19(1):38-45.
Adherence with statin therapy in elderly patients with and without acute coronary syndromes
Jackevicius CA, Mamdani M, Tu JV. JAMA. 2002; 288(4):462-7.
Use of the statins in patients after acute myocardial infarction: does evidence change practice?
Jackevicius CA, Anderson GM, Leiter L, Tu JV. Arch Intern Med. 2001; 161(2):183-8.